MOUNJARO tirzepatide 15 mg/0.5 mL solution for injection vial

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: cd145d1f13975085
Product Name: MOUNJARO tirzepatide 15 mg/0.5 mL solution for injection vial
Artg Id: 407054
Artg Name: MOUNJARO tirzepatide 15 mg/0.5 mL solution for injection vial
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2023-07-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02113-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-02114-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cd145d1f13975085

Type

Standard